Abstract Previous prospective studies have shown inconsistent associations between serum 25-hydroxyvitamin D [25(OH)D] level and lung cancer incidence. The aim of the present study was to explore the associations of serum 25(OH)D levels with incidence of lung cancer overall and different histologic types. We performed a populationbased prospective case-cohort study including 696 incident lung cancer cases and 5804 individuals in a subcohort who participated in the second survey of the Nord-Trøndelag Health Study in Norway. Cox proportional hazards regression models counting for the case-cohort design were used to estimate hazard ratios (HRs) with 95% confidence interval (CIs) for lung cancer overall or histologic types in 
Introduction
Lung cancer has been the most common cancer type for several decades worldwide. In 2012, there were an estimated 1.8 million new cases, which represented 13% of all new cases of cancer [1] . Lung cancer is also the most lethal cancer, and the overall ratio of mortality to incidence is 0.87 [1] . About 1.6 million people died of lung cancer worldwide in 2012 (19.4% of the total cancer mortality). The two broad histological classes of lung cancer are small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) [2] . NSCLC has two further major subtypes: adenocarcinoma and squamous cell carcinoma. Smoking is strongly associated with an increased risk of SCLC and squamous cell carcinoma, whereas the association between smoking and non-small-cell adenocarcinoma is much weaker [3] . Adenocarcinoma is the most common histologic type of lung cancer in most countries, and recent research shows that the incidence rate of adenocarcinoma is increasing [4, 5] . Therefore, exploration of other risk factors apart from tobacco smoking and a better understanding of the pathogenesis of different histologic types of lung cancer are essential for further prevention of lung cancer.
Vitamin D has been suggested to have a number of anticarcinogenic potentials, including inducing differentiation, and inhibiting proliferation, invasiveness, angiogenesis and metastatic properties [6, 7] . Vitamin D deficiency is quite common worldwide [8, 9] . In our previous study of adults living in the Central Norway, the prevalence of vitamin D deficiency [defined by serum 25-hydroxyvitamin D (25(OH)D) level \ 50 nmol/L] was about 60% [10] . Vitamin D deficiency is likely to have impact on various chronic diseases [9, 11] . The majority of previous prospective studies did not observe any association between serum 25(OH)D level and lung cancer incidence [12] [13] [14] [15] [16] [17] [18] , except for one study showing an inverse association [19] . These studies were generally small in sample size and did not evaluate possible associations with lung cancer histologic types.
Therefore, we performed for the first time a case-cohort study aiming to explore the potential associations of serum 25(OH)D levels with incidence of lung cancer overall and histologic types. We also evaluated if sex, active smoking and body mass index (BMI) had any modifying effects on the associations of serum 25(OH)D levels with incidence of lung cancer overall and histologic types.
Materials and methods

Study population, data linkage and study design
The Nord-Trøndelag Health Study (HUNT) is one of the largest and most comprehensive population surveys conducted in Norway [20] . All inhabitants aged 20 years or older in the county of Nord-Trøndelag were invited to participate in three separate surveys: HUNT1 (1984) (1985) (1986) , HUNT2 (1995 HUNT2 ( -1997 and HUNT3 (2006 HUNT3 ( -2008 . Blood and DNA samples were collected in both HUNT2 and HUNT3 and stored in a modern biobank at the HUNT Research Center. We used data and serum samples collected in HUNT2 to assure a longer follow-up duration. Briefly, in 1995-1997 approximately 93,000 adults were invited to participate in HUNT2 and 65,229 people participated (response rate 70%). All participants in HUNT2 were requested to complete a general questionnaire including health and lifestyle questions and social economic status. At the clinical examination body weight and height were measured by trained nurses. The HUNT Research Center also received updated information about deaths of all causes and emigration of the HUNT participants from the Norwegian National Registry in which the dates of such events were recorded for all people living in Norway.
Using the unique 11-digit personal identification number for all residents in Norway, the HUNT2 population data were linked with data from the Cancer Registry of Norway [21] . The ICD-10 topography codes used for registration of lung cancer were C33-C34 [22] . Histologic types were classified according to International Classification of Diseases of Oncology (ICD-O) [23] .
We performed a prospective case-cohort study using Prentice method and robust estimation of the variance [24, 25] . Incident cases were those diagnosed with lung cancer until December 31, 2014 among the HUNT2 study population (n = 841). The subcohort was a 10% random sample of the HUNT2 participants (n = 6613, including 6521 non-cases and 92 cases). We then excluded subjects who reported ever cancer in the questionnaire at baseline, lung cancer cases diagnosed before the participation date in the HUNT2 study, as well as subjects without data on the vitamin D level due to lack of serum. This left 696 incident lung cancer cases and 5725 non-cases for the statistical analyses. Figure 1 depicts the inclusion and exclusion of the subjects in the cases and the subcohort. The study was approved by the Norwegian Regional Committees for Medical and Health Research Ethics.
Measurement and classification of serum 25(OH)D levels
Serum 25(OH)D levels were measured at the HUNT Biobank using LIAISON 25-OH Vitamin D TOTAL (DiaSorin, Saluggia, Italy), a fully automated, antibody-based, chemiluminescence assay. The detection range of the assay is 10-375 nmol/L. This is a well-developed method and has been proven as a rapid, accurate and precise tool for the measurement of serum 25(OH)D levels [26] . Because seasonal fluctuations in 25(OH)D levels were expected due to the high-latitude geographical position of Norway, season-specific quartiles derived from the subcohort were used to categorize 25(OH)D levels [27] . The fourth quartile was used as the reference group since the median of the fourth quartile (68.0 nmol/L) corresponded well with the cut-off level of 50.0-74.9 nmol/L that was suggested as sufficient according to the National Academy of Sciences report [28] .
Information on covariates
Data of baseline variables were collected by questionnaires or clinical examination in HUNT2. These covariates were categorized as following: sex (women, men), season of blood draw (spring: March-May, summer: June-August, fall: September-November, winter: December-February), pack-years of active smoking [0 (never smokers), 0-10.0, 10.1-20.0, C 20.1], passive smoking exposure (never, childhood only, adulthood only, both periods), family history of cancer (Is there any family member such as father, mother, siblings who reported cancer? yes/no), education (\ 10, 10-12, C 13 years), economic difficulties (During the last year, has it at any time been difficult to meet the costs of food, transportation, housing and such? yes/no), BMI (\ 25.0, 25.0-29.9, C 30.0 kg/m 2 ) or as a continuous variable, physical activity (inactive or very low, low, moderate, high), alcohol consumption (never, 1-4, C 5 times/month), and chronic bronchitis (Have you had a cough with phlegm for periods of at least 3 months during each of the last 2 years? yes/no).
Statistical analyses
Cox proportional hazards regression models counting for the case-cohort design (command stcascoh in Stata) were used to compute hazard ratios (HRs) with 95% confidence intervals (CIs) for the incidence of lung cancer overall or histologic types in relation to serum 25(OH)D levels [25] . Age was used as time axis in the models. The subjects in the case-cohort were followed up from their participation date in HUNT2 study up to the date of lung cancer diagnosis, death due to other causes, emigration or end of follow-up (December 31, 2014), whichever occurred first. When one histologic type was outcome, all other types and emigration/death were regarded as censored. The proportional hazards assumption was satisfied for serum 25(OH)D levels and covariates in most circumstances. In some occasions when lung cancer overall, NSCLC, or adenocarcinoma was the outcome, sex and economic difficulties showed non-proportional hazards and we used the tvc option of the stcox command in Stata to model these.
Two multivariable models were presented. In Model 1 sex, pack-years of active smoking, passive smoking exposure, family history of cancer, education, economic difficulties and BMI were adjusted. In Model 2 we adjusted for physical activity, alcohol consumption, and chronic bronchitis in addition to the variables included in Model 1. The associations of lifestyle factors such as physical activity and alcohol consumption with lung cancer incidence are not yet confirmed. Chronic bronchitis may be either a confounder or a mediator in the causal pathway between 25(OH)D and lung cancer, and over-adjustment is possible if the latter was the case. Therefore, results from Model 1 were presented as the main findings in this report. Furthermore, the associations of 25(OH)D with lung cancer overall and histologic types were stratified by sex, active smoking status and BMI respectively. The potential effect modifications by these variables were evaluated by Wald tests. To reduce possible reverse causality by existing but undiagnosed lung cancer on the serum 25(OH)D levels, we performed analyses excluding the first 5 years of followup.
For sensitivity analysis, we used the commonly used cut-off groups (\ 25.0, 25.0-49.9, 50.0-74.9, C 75.0 nmol/L) to categorize the levels of serum 25(OH)D and controlled for season of blood draw. The level of 50.0-74.9 nmol/L was used as the reference group [28] . All statistical analyses were performed with Stata/SE 14.2 (College Station, TX, USA). Table 1 presents the distributions of baseline characteristics in the incident lung cancer cases (n = 696) and noncases from the subcohort (n = 5725). In general, those with lung cancer were older and had slightly higher 25(OH)D levels than the non-cases. The distributions of other baseline characteristics differed considerably between the lung cancer cases and non-cases apart from season of blood draw and BMI. The distributions of baseline characteristics by season-specific quartiles of 25(OH)D in the subcohort are presented in Supplementary  Table 1 . Table 2 The associations between lower 25(OH)D levels and a lower risk of adenocarcinoma were only observed in the overweight/obese subjects, although test of statistical interaction gave a p value of 0.16 (Table 3 ). Compared to the fourth quartile reference group, HRs for adenocarcinoma associated with the first to third quartiles were 0.58 (95% CI 0.31-1.07), 0.40 (0.22-0.72) and 0.50 (0.27-0.92) in the overweight/obese subjects and 1.04 (0.56-1.93), 0.95 (0.52-1.75) and 0.60 (0.32-1.10)] in the normal/underweight subjects, respectively. There was no evidence that sex or smoking modified the associations between 25(OH)D levels and risk of lung cancer overall or histologic types (Supplementary Tables 2 and 3) .
Results
To address possible bias due to reverse causation we repeated the analyses after excluding the first five years of follow-up in the total sample and stratified BMI groups (Table 4) . Lower serum 25(OH)D levels were associated with lower risk of NSCLC and adenocarcinoma in the total and overweight/obese subjects. Moreover, sensitivity analyses using the commonly used cut-off values to define the 25(OH)D categories gave similar results ( Table 5 ). The 25(OH)D level of 25.0-49.9 nmol/L was associated with a lower risk of NSCLC and adenocarcinoma in the total sample as well as the overweight/obese subgroup.
Discussion Main findings
In this case-cohort study with 696 incident lung cancer cases, there was no clear association of lower serum 25(OH)D level with risk of lung cancer overall, SCLC or squamous cell carcinoma. Nevertheless, we observed an association between lower 25(OH)D levels and lower risk of adenocarcinoma, especially in the overweight/obese subjects.
Comparison with other studies
Our observation that lower serum 25(OH)D levels were not associated with risk of lung cancer overall is consistent with the null association observed in most of the previous observational studies [12] [13] [14] [15] [16] [17] [18] . Conversely, Afzal et al. [19] showed that a 50% reduction of plasma 25(OH)D level was associated with a 19% increased risk for lung cancer overall. Another prospective study demonstrated that women and young participants with a higher level of vitamin D had a lower risk of lung cancer [13] . However, previous studies in general had much smaller number of lung cancer cases and lacked information on histologic types.
Our findings that lower 25(OH)D levels were associated with a lower risk of adenocarcinoma were unexpected and contrary to the predominating hypothesis generated from in vitro experiments and animal models in which vitamin D was beneficial in protecting against development of cancer [7] . Epidemiological studies have also shown that low levels of vitamin D was associated with increased incidence of digestive system cancers [12, 29] . However, the pathophysiological roles of vitamin D in the development of cancers are complicated. Several prospective studies reported a positive relationship between vitamin D level and risk of prostate cancer [18, 30] . Worthy of note, our study suggested a reduced risk of pulmonary adenocarcinoma in relation to lower levels of serum 25(OH)D. There was no strong statistical evidence suggesting that the level of 25(OH)D C 75 nmol/L was associated with higher risk of adenocarcinoma (Table 5 ), but we could not adequately evaluate the relation of 25(OH)D level C 100 nmol/L with risk of adenocarcinoma due to the small number of individuals (n = 56).
Strengths and limitations
Our study is the first prospective case-cohort study to investigate the associations of serum 25(OH)D levels with the risk of lung cancer histologic types, including a large number of cases. Information about diagnosis of lung cancer and histologic types was recorded and updated 1 year after diagnosis at the Cancer Registry of Norway [21] . The information was almost complete and reasonably accurate, and therefore misclassification of lung cancer was less likely [31] . Serum 25(OH)D level is widely recognized as the best available proxy measure for vitamin D status [32] . Any misclassification of vitamin D due to measurement error would be non-differential as blood samples had been collected before the events occurred. Besides, serum samples from the cases and subcohort were placed in a random manner during the measurement so that major batch effects can be excluded. In addition, we were able to adjust for a broad panel of confounding factors in the regression models, and the season-specific quartiles and cut-off groups showed consistent results with incidence of lung cancer overall and adenocarcinoma. This study had several potential limitations. As participants in the HUNT studies were shown to be healthier than non-participants, our findings might differ to some degree from the factual situation in the general Norwegian population [33] . One may question if the one-time measurement of 25(OH)D level at baseline can reflect the long-term exposure of low vitamin D. Previous studies suggested that 25(OH)D concentrations were relatively stable during a long-term follow-up [34, 35] . A Norwegian study showed a moderate correlation between serum 25(OH)D measurements 14 years apart [34] . Moreover, Norwegians have a long tradition to take cod liver oil as vitamin D supplement, which is also recommended by The Norwegian Directorate of Health. Therefore we assume that the level of vitamin D intake and/or status has not changed significantly in the Norwegian population over these years. Liaison immunoassay method tends to underestimate the true 25(OH)D levels [36, 37] . Caution is thus warranted when our results are compared with those using other assay methods [36] . Our observation that lower 25(OH)D levels were associated with a reduced risk of pulmonary adenocarcinoma cannot be explained by the potential residual confounding of tobacco smoking. If the residual confounding of smoking could be removed completely, we would expect to see the association estimates to be more away from the null (HR = 1). This is because tobacco smoking is inversely associated with serum 25(OH)D levels (10) but positively associated with the risk of lung cancer. Observational studies have shown an inverse relation between BMI and lung cancer risk, especially among former and current smokers [38, 39] . Although residual confounding by smoking might explain the inverse association of obesity with lung cancer, a recent Mendelian randomization study suggested a possible causal association between genetically determined higher BMI and a reduced risk for pulmonary adenocarcinoma [40] . Another Mendelian randomization analysis of multiple cohorts suggested that higher BMI resulted in lower serum 25(OH)D levels [41] . Thus, BMI was considered as an important confounding factor or effect modifier in the current study. Even though we controlled for BMI as either a categorical or continuous variable, we cannot rule out possible residual confounding by adiposity or unmeasured adiposity related factors, especially when we observed that lower 25(OH)D levels were associated with a lower risk of adenocarcinoma in the overweight/obese subgroup but not in the normal weight group.
Unmeasured factors that may confound the association could be other dietary factors, such as fruits and vegetables intake, and vitamin A level/intake. It has been shown that higher intake of fruits and vegetables, vitamin A and beta-carotene is associated with a lower risk of lung cancer [42, 43] . However, the causal relation between these factors and lung cancer risk is unclear. In addition, we are not aware of studies that have examined how these dietary factors may influence the serum vitamin D level. Serum 25(OH)D level is a biomarker reflecting the integrated level due to sun exposure, dietary intake and supplement of vitamin D [28] . There was no information on the aforementioned nutritional factors available in our data, but adjusting for cod liver oil intake did not change the estimated HRs.
Reverse association between 25(OH)D and pulmonary adenocarcinoma in our findings was less likely since the association remained after we excluded the first 5 years of follow-up. Moreover, 24-hydroxylase, encoded by CYP24A1, was overexpressed in adenocarcinoma of lung Finally, our findings were derived from a homogeneous Norwegian population, which may limit the generalizability. It would be important to investigate this association in other populations, such as in Asia where there is very high incidence of lung cancer, and in particular adenocarcinoma [5] . Mendelian randomization studies using vitamin D genetic variants are also called for to test if there is any life-time causal association between vitamin D levels and lung cancer in general as well as adenocarcinoma in particular.
Conclusions
In summary, lower serum 25(OH)D levels were not associated with the risk of lung cancer in general. Our observation that lower 25(OH)D levels were associated with a lower risk of adenocarcinoma should be interpreted with caution, as we cannot rule out the reduced risk is due to bias. Author Contributions YQS, AL, YC and XMM contributed to the study design. XMM and AL contributed to data collection. CW contributed to statistical analyses. YQS conducted statistical analyses, interpreted results and wrote the initial draft of the manuscript. AL, CW, FS, YC, TILN, PRR and XMM participated in the data interpretation and helped to write the final draft of the manuscript.
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